Your browser doesn't support javascript.
loading
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE-MM2 trial.
Richardson, Paul G; Facon, Thierry; Venner, Christopher P; Bahlis, Nizar J; Offner, Fritz; White, Darrell; Karlin, Lionel; Benboubker, Lotfi; Voog, Eric; Yoon, Sung-Soo; Suzuki, Kenshi; Shibayama, Hirohiko; Zhang, Xiaoquan; Villarreal, Miguel; Twumasi-Ankrah, Philip; Labotka, Richard; Rifkin, Robert M; Lonial, Sagar; Kumar, Shaji K; Rajkumar, S Vincent; Moreau, Philippe.
Afiliação
  • Richardson PG; Harvard Medical School Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute Boston Massachusetts USA.
  • Facon T; Centre Hospitalier Universitaire (CHU) Lille Service des Maladies du Sang, University of Lille Lille France.
  • Venner CP; Cross Cancer Institute University of Alberta Edmonton Alberta Canada.
  • Bahlis NJ; BC Cancer Vancouver Centre University of British Columbia Vancouver British Columbia Canada.
  • Offner F; Arnie Charbonneau Cancer Institute University of Calgary Calgary Alberta Canada.
  • White D; UZ Gent Gent Belgium.
  • Karlin L; QEII Health Sciences Center and Dalhousie University Halifax Nova Scotia Canada.
  • Benboubker L; Hôpital Lyon Sud, Pierre-Benite Lyon France.
  • Voog E; CHRU TOURS Tours France.
  • Yoon SS; Clinique Victor Hugo Le Mans France.
  • Suzuki K; Department of Internal Medicine Seoul National University Hospital Seoul Republic of Korea.
  • Shibayama H; Japan Red Cross Medical Center Shibuya-ku Tokyo Japan.
  • Zhang X; Osaka University Graduate School of Medicine Suita Osaka Japan.
  • Villarreal M; Takeda Development Center Americas, Inc. (TDCA) Lexington Massachusetts USA.
  • Twumasi-Ankrah P; Takeda Development Center Americas, Inc. (TDCA) Lexington Massachusetts USA.
  • Labotka R; Takeda Development Center Americas, Inc. (TDCA) Lexington Massachusetts USA.
  • Rifkin RM; Takeda Development Center Americas, Inc. (TDCA) Lexington Massachusetts USA.
  • Lonial S; US Oncology Research - Rocky Mountain Cancer Centers Denver Colorado USA.
  • Kumar SK; Department of Hematology and Medical Oncology Winship Cancer Institute Emory University School of Medicine Atlanta Georgia USA.
  • Rajkumar SV; Mayo Clinic Rochester Minnesota USA.
  • Moreau P; Mayo Clinic Rochester Minnesota USA.
EJHaem ; 4(4): 995-1005, 2023 Nov.
Article em En | MEDLINE | ID: mdl-38024593
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EJHaem Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: EJHaem Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos